{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2021:QGK7ZIEXZAOELFYTLMX32V6INW","short_pith_number":"pith:QGK7ZIEX","schema_version":"1.0","canonical_sha256":"8195fca097c81c4597135b2fbd57c86dbd1ca317895be9a2026b013f5a336367","source":{"kind":"arxiv","id":"2103.02843","version":2},"attestation_state":"computed","paper":{"title":"Pandemic Drugs at Pandemic Speed: Infrastructure for Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":["cs.CE","cs.LG","physics.bio-ph","q-bio.QM"],"primary_cat":"cs.DC","authors_text":"Agastya P. Bhati, Alberto Di Meglio, Alexander Partin, Anda Trifan, Andre Merzky, Arvind Ramanathan, Austin R. Clyde, Dario Alf\\`e, David Wifling, Dieter Kranzlm\\\"uller, Fangfang Xia, Gerald Mathias, Heng Ma, Li Tan, Mathis Bode, Matteo Turilli, Mikhail Titov, Nicola Scafuri, Peter V. Coveney, Rick Stevens, Roger R. Highfield, Sauro Succi, Shantenu Jha, Shunzhou Wan, Sofia Vallecorsa, Tom Brettin, Walter Rocchia, Xiaotan Duan, Yann Donon","submitted_at":"2021-03-04T05:43:18Z","abstract_excerpt":"The race to meet the challenges of the global pandemic has served as a reminder that the existing drug discovery process is expensive, inefficient and slow. There is a major bottleneck screening the vast number of potential small molecules to shortlist lead compounds for antiviral drug development. New opportunities to accelerate drug discovery lie at the interface between machine learning methods, in this case developed for linear accelerators, and physics-based methods. The two in silico methods, each have their own advantages and limitations which, interestingly, complement each other. Here"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2103.02843","kind":"arxiv","version":2},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"cs.DC","submitted_at":"2021-03-04T05:43:18Z","cross_cats_sorted":["cs.CE","cs.LG","physics.bio-ph","q-bio.QM"],"title_canon_sha256":"0ede537f40716fa89128330ddefc0270a3cea39abb0109b11af6cf81d5d8e8f3","abstract_canon_sha256":"967c6eb0d210fa2adbf25222c6476bc0b891bf08251c0f556dd8a86bf331a608"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T03:26:59.299580Z","signature_b64":"jOZhgc6eGEZ4DiK/cm4G9G8qKzbs75m4E6SSNkrivufp8rwQNl8b4U83Wr34aB5wU3rQAXtj+JdnGyr8why/DA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"8195fca097c81c4597135b2fbd57c86dbd1ca317895be9a2026b013f5a336367","last_reissued_at":"2026-07-05T03:26:59.298456Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T03:26:59.298456Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Pandemic Drugs at Pandemic Speed: Infrastructure for Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":["cs.CE","cs.LG","physics.bio-ph","q-bio.QM"],"primary_cat":"cs.DC","authors_text":"Agastya P. Bhati, Alberto Di Meglio, Alexander Partin, Anda Trifan, Andre Merzky, Arvind Ramanathan, Austin R. Clyde, Dario Alf\\`e, David Wifling, Dieter Kranzlm\\\"uller, Fangfang Xia, Gerald Mathias, Heng Ma, Li Tan, Mathis Bode, Matteo Turilli, Mikhail Titov, Nicola Scafuri, Peter V. Coveney, Rick Stevens, Roger R. Highfield, Sauro Succi, Shantenu Jha, Shunzhou Wan, Sofia Vallecorsa, Tom Brettin, Walter Rocchia, Xiaotan Duan, Yann Donon","submitted_at":"2021-03-04T05:43:18Z","abstract_excerpt":"The race to meet the challenges of the global pandemic has served as a reminder that the existing drug discovery process is expensive, inefficient and slow. There is a major bottleneck screening the vast number of potential small molecules to shortlist lead compounds for antiviral drug development. New opportunities to accelerate drug discovery lie at the interface between machine learning methods, in this case developed for linear accelerators, and physics-based methods. The two in silico methods, each have their own advantages and limitations which, interestingly, complement each other. Here"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2103.02843","kind":"arxiv","version":2},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2103.02843/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2103.02843","created_at":"2026-07-05T03:26:59.298543+00:00"},{"alias_kind":"arxiv_version","alias_value":"2103.02843v2","created_at":"2026-07-05T03:26:59.298543+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2103.02843","created_at":"2026-07-05T03:26:59.298543+00:00"},{"alias_kind":"pith_short_12","alias_value":"QGK7ZIEXZAOE","created_at":"2026-07-05T03:26:59.298543+00:00"},{"alias_kind":"pith_short_16","alias_value":"QGK7ZIEXZAOELFYT","created_at":"2026-07-05T03:26:59.298543+00:00"},{"alias_kind":"pith_short_8","alias_value":"QGK7ZIEX","created_at":"2026-07-05T03:26:59.298543+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/QGK7ZIEXZAOELFYTLMX32V6INW","json":"https://pith.science/pith/QGK7ZIEXZAOELFYTLMX32V6INW.json","graph_json":"https://pith.science/api/pith-number/QGK7ZIEXZAOELFYTLMX32V6INW/graph.json","events_json":"https://pith.science/api/pith-number/QGK7ZIEXZAOELFYTLMX32V6INW/events.json","paper":"https://pith.science/paper/QGK7ZIEX"},"agent_actions":{"view_html":"https://pith.science/pith/QGK7ZIEXZAOELFYTLMX32V6INW","download_json":"https://pith.science/pith/QGK7ZIEXZAOELFYTLMX32V6INW.json","view_paper":"https://pith.science/paper/QGK7ZIEX","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2103.02843&json=true","fetch_graph":"https://pith.science/api/pith-number/QGK7ZIEXZAOELFYTLMX32V6INW/graph.json","fetch_events":"https://pith.science/api/pith-number/QGK7ZIEXZAOELFYTLMX32V6INW/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/QGK7ZIEXZAOELFYTLMX32V6INW/action/timestamp_anchor","attest_storage":"https://pith.science/pith/QGK7ZIEXZAOELFYTLMX32V6INW/action/storage_attestation","attest_author":"https://pith.science/pith/QGK7ZIEXZAOELFYTLMX32V6INW/action/author_attestation","sign_citation":"https://pith.science/pith/QGK7ZIEXZAOELFYTLMX32V6INW/action/citation_signature","submit_replication":"https://pith.science/pith/QGK7ZIEXZAOELFYTLMX32V6INW/action/replication_record"}},"created_at":"2026-07-05T03:26:59.298543+00:00","updated_at":"2026-07-05T03:26:59.298543+00:00"}